NZ627941A - Hatching fluid enzymes and uses thereof - Google Patents

Hatching fluid enzymes and uses thereof

Info

Publication number
NZ627941A
NZ627941A NZ62794110A NZ62794110A NZ627941A NZ 627941 A NZ627941 A NZ 627941A NZ 62794110 A NZ62794110 A NZ 62794110A NZ 62794110 A NZ62794110 A NZ 62794110A NZ 627941 A NZ627941 A NZ 627941A
Authority
NZ
New Zealand
Prior art keywords
sequence
skin
set forth
seq
amino acids
Prior art date
Application number
NZ62794110A
Other languages
English (en)
Inventor
Hans Kristian Leren
Bernt Walther
Original Assignee
Aqua Bio Technology Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41572950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ627941(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aqua Bio Technology Asa filed Critical Aqua Bio Technology Asa
Publication of NZ627941A publication Critical patent/NZ627941A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24066—Choriolysin L (3.4.24.66)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)
NZ62794110A 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof NZ627941A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0921001A GB0921001D0 (en) 2009-11-30 2009-11-30 Products and uses
NZ60049910A NZ600499A (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Publications (1)

Publication Number Publication Date
NZ627941A true NZ627941A (en) 2015-01-30

Family

ID=41572950

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ62794110A NZ627941A (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof
NZ60049910A NZ600499A (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ60049910A NZ600499A (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Country Status (17)

Country Link
US (3) US9133256B2 (enExample)
EP (1) EP2506825B2 (enExample)
JP (1) JP5913117B2 (enExample)
KR (1) KR101842521B1 (enExample)
CN (2) CN104436163B (enExample)
AU (2) AU2010323022B2 (enExample)
CA (1) CA2781834C (enExample)
CL (1) CL2012001380A1 (enExample)
ES (1) ES2741586T5 (enExample)
GB (1) GB0921001D0 (enExample)
IN (1) IN2012DN04918A (enExample)
MX (1) MX340231B (enExample)
NZ (2) NZ627941A (enExample)
PL (1) PL2506825T5 (enExample)
RU (1) RU2595399C2 (enExample)
WO (1) WO2011064384A1 (enExample)
ZA (1) ZA201204066B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201110783D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110777D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
MX346043B (es) * 2012-01-06 2017-03-03 Novus Int Inc Tensioactivos basados en sulfoxido.
DK3100717T3 (da) * 2012-01-23 2022-01-10 Restorsea Llc Kosmetikprodukt indeholdende et fiskerognsproteinisolat
GB201223330D0 (en) * 2012-12-21 2013-02-06 Aqua Bio Technology Asa Products, methods and uses
BR112015014532B1 (pt) * 2012-12-21 2021-08-24 Aqua Bio Technology Asa Método para preparar uma composição cosmética de fluido de eclosão de peixe
KR101505294B1 (ko) * 2013-06-19 2015-03-23 강릉원주대학교산학협력단 켈로이드 또는 흉터 형성을 감소시키기 위한 조성물
MX2016007617A (es) 2013-12-13 2016-10-04 Restorsea Llc Formulacion exfoliante para promover la retencion del cabello.
WO2015175333A1 (en) 2014-05-16 2015-11-19 Restorsea, Llc Biphasic cosmetic
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions
JP7776142B2 (ja) * 2019-07-05 2025-11-26 レゲニクス アーエス 創傷デブリードマンのシステム
CN110592054B (zh) * 2019-08-29 2021-02-12 中国科学院南海海洋研究所 海马孵化酶基因及其编码蛋白和应用
KR20240100757A (ko) * 2022-12-23 2024-07-02 순천향대학교 산학협력단 철갑상어 점액질을 유효성분으로 포함하는 상처 치유 또는 여드름 치료용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3393559B2 (ja) * 1993-10-15 2003-04-07 株式会社ノエビア 皮膚外用剤
FR2743723B1 (fr) 1996-01-18 1998-04-17 Texinfine Sa Utilisation d'extrait des plantes de la famille des dictyotales en vue de la realisation de preparations destinees a remanier les elements glycosyles de la matrice extracellulaire de tissus vivants
NO314594B1 (no) † 1997-12-11 2003-04-14 Aqua Bio Technology As Ikke-selvdegraderende endoprotease, fremgangsmåte for fremstilling samt anvendelser av denne
AU766674B2 (en) 1998-05-27 2003-10-23 Lauras As Method
FR2792202B1 (fr) * 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
JP4643800B2 (ja) * 2000-06-16 2011-03-02 エム・ディジャパン株式会社 プロテアーゼ阻害剤
WO2002066624A2 (en) 2001-02-20 2002-08-29 Lexicon Genetics Incorporated Novel human protease and polynucleotides encoding the same
US20050074865A1 (en) † 2002-08-27 2005-04-07 Compound Therapeutics, Inc. Adzymes and uses thereof
GB0230006D0 (en) * 2002-12-23 2003-01-29 Ares Trading Sa Proteins
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
EP1689766B1 (en) 2003-11-06 2012-04-25 Danisco US Inc. Expression in filamentous fungi of protease inhibitors and variants thereof
EP1692159B1 (en) * 2003-11-06 2010-09-29 Danisco US Inc. Tgf-beta1 binding and supported peptides
US8357365B2 (en) * 2005-02-14 2013-01-22 The Regents Of The University Of California Granulysin peptides and methods of use thereof
JP2008094726A (ja) 2006-10-06 2008-04-24 Towa Koso Kk マイクロバブル洗浄用組成物、マイクロバブル洗浄方法及びマイクロバブル洗浄装置

Also Published As

Publication number Publication date
CA2781834A1 (en) 2011-06-03
US9950031B2 (en) 2018-04-24
ZA201204066B (en) 2013-08-28
CN102724954A (zh) 2012-10-10
JP2013511971A (ja) 2013-04-11
JP5913117B2 (ja) 2016-04-27
US9624483B2 (en) 2017-04-18
WO2011064384A1 (en) 2011-06-03
PL2506825T3 (pl) 2019-11-29
MX340231B (es) 2016-07-01
BR112012012909A2 (pt) 2017-04-18
AU2015202010A1 (en) 2015-05-14
AU2010323022B2 (en) 2015-05-14
ES2741586T5 (es) 2023-08-18
ES2741586T3 (es) 2020-02-11
GB0921001D0 (en) 2010-01-13
CN102724954B (zh) 2018-07-27
CL2012001380A1 (es) 2012-11-30
CN104436163A (zh) 2015-03-25
CA2781834C (en) 2019-02-12
AU2010323022A1 (en) 2012-06-21
MX2012006090A (es) 2012-09-07
NZ600499A (en) 2014-09-26
EP2506825B2 (en) 2023-05-31
KR20120115291A (ko) 2012-10-17
RU2012127298A (ru) 2014-01-20
CN104436163B (zh) 2017-08-11
US20160053249A1 (en) 2016-02-25
KR101842521B1 (ko) 2018-03-27
IN2012DN04918A (enExample) 2015-09-25
EP2506825B1 (en) 2019-05-08
RU2595399C2 (ru) 2016-08-27
AU2015202010B2 (en) 2017-04-20
US20120309689A1 (en) 2012-12-06
EP2506825A1 (en) 2012-10-10
PL2506825T5 (pl) 2023-07-10
US9133256B2 (en) 2015-09-15
US20170189478A1 (en) 2017-07-06

Similar Documents

Publication Publication Date Title
NZ627941A (en) Hatching fluid enzymes and uses thereof
AU2016366220B2 (en) Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes
CN104968360B (zh) 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物
NZ592911A (en) Leukolectins and uses thereof
WO2010135491A3 (en) Fibroblast growth factor mutants having improved functional half-life and methods of their use
NZ601868A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
NZ598348A (en) Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
NZ602471A (en) Antagonists of activin-actriia and uses for increasing red blood cell levels
NZ621868A (en) Growth hormone polypeptides and methods of making and using same
MX2009012650A (es) Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos.
WO2011036445A3 (en) Polypeptides and uses thereof
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
NZ610620A (en) Inhibitors of apoptosis and uses thereof
WO2008068422A3 (fr) Utilisation cosmetique d'une proteine de la famille des ribonucleases
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
NZ602702A (en) Modified fgf-21 polypeptides and their uses
CN110944677A (zh) 局部组合物及用途
EP4349361A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
KR102077983B1 (ko) 피부 주름 개선 및 미백용 조성물
JP6153469B2 (ja) ダイズタンパク質の加水分解物を含有する組成物
KR101305274B1 (ko) 콜라겐 합성 촉진용 조성물
CN110078793A (zh) 一种具有抗衰老和修复作用的多肽及其用途
JP2009507474A5 (enExample)
WO2010065536A3 (en) Recombinant bone marrow stromal antigen-2 in the treatment of autoimmune diseases
WO2012073048A3 (en) Variants of ignar

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 NOV 2017 BY LEA

Effective date: 20150807

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2018 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20171122

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2019 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20181120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2020 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20191121

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2021 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20201120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2022 BY CAMILLA WELLIN / CPA GLOBAL CLARIVATE

Effective date: 20211120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2023 BY PATENT ANNUITIES 2022-11-21

Effective date: 20221121

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2024 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20231124

LAPS Patent lapsed